Issues and Innovations in Drug Development presented by Aptuit Thank you for subscribing to our podcast series. Aptuit will continually update the series with interviews from experts across the entire drug development continuum. http://www.aptuit.com News 2008. All Rights Reserved http://blogs.law.harvard.edu/tech/rss en Wed, 11 Mar 2009 20:30:27 -0400 webcast@multivu.com Mon, 8 Sep 2008 09:00:00 -0400 webcast@multivu.com FeedForAll v2.0 (2.0.2.9) http://www.feedforall.com http://www.prnewswire.com/webcast/images/aptuit_logo.jpg Issues and Innovations in Drug Development presented by Aptuit http://www.aptuit.com aptuit Logo 128 128 Redefining the CRO In this episode, Bob Burford Ph.D., Managing Director, Aptuit Consulting discusses the relationship between drug developers and CROs, including current market conditions, the changing needs of drug developers, how to choose an outsourcing provider, expectations of a CRO, and the future of this important relationship. http://www.aptuit.com 3AD825CB-A243-429A-BE9D-126D8C6708A0 Mon, 8 Sep 2008 15:00:00 -0400 Informatics and clinical supply chain management: A stronger link for the drug development In this installment of the series, Doug Meyer, Senior Director for Aptuit Informatics, discusses the role and importance of informatics in today’s clinical trial environment. http://www.aptuit.com 01E4C8EB-9B3F-40F7-8171-A85BD49CEEA5 Mon, 8 Sep 2008 09:00:00 -0400 Molecular Design and the Critical Path Problem In this episode, Dr. Stephen Byrn, Head of Aptuit Scientific Advisory Board, speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process. http://www.aptuit.com CB293744-D69E-4E1B-9FBE-EEACFE1D3BF2 Tue, 9 Sep 2008 17:00:00 -0400